Literature DB >> 26530302

To notify or not to notify: decision aid for policy makers on whether to make an infectious disease mandatorily notifiable.

Paul Bijkerk1, Ewout B Fanoy, Katina Kardamanidis, Simone M van der Plas, Margreet J Te Wierik, Mirjam E Kretzschmar, George B Haringhuizen, Hans J van Vliet, Marianne A van der Sande.   

Abstract

Mandatory notification can be a useful tool to support infectious disease prevention and control. Guidelines are needed to help policymakers decide whether mandatory notification of an infectious disease is appropriate. We developed a decision aid, based on a range of criteria previously used in the Netherlands or in other regions to help decide whether to make a disease notifiable. Criteria were categorised as being effective, feasible and necessary with regard to the relevance of mandatory notification. Expert panels piloted the decision aid. Here we illustrate its use for three diseases (Vibrio vulnificus infection, chronic Q fever and dengue fever) for which mandatory notification was requested. For dengue fever, the expert panel advised mandatory notification; for V. vulnificus infection and chronic Q fever, the expert panel concluded that mandatory notification was not (yet) justified. Use of the decision aid led to a structured, transparent decision making process and a thorough assessment of the advantages and disadvantages of mandatory notification of these diseases. It also helped identify knowledge gaps that required further research before a decision could be made. We therefore recommend use of this aid for public health policy making.

Entities:  

Keywords:  Infectious diseases; Mandatory notification; Surveillance; decision aid

Mesh:

Year:  2015        PMID: 26530302     DOI: 10.2807/1560-7917.ES.2015.20.34.30003

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  6 in total

1.  Ebola in the Netherlands, 2014-2015: costs of preparedness and response.

Authors:  Anita W M Suijkerbuijk; Corien M Swaan; Marie-Josee J Mangen; Johan J Polder; Aura Timen; Wilhelmina L M Ruijs
Journal:  Eur J Health Econ       Date:  2017-11-17

Review 2.  [Mandatory notification of infectious diseases and agents in Germany: development and suggestions for improvement].

Authors:  Ursel Heudorf; René Gottschalk
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2020-06       Impact factor: 1.513

3.  A prospective cohort study to assess seroprevalence, incidence, knowledge, attitudes and practices, willingness to pay for vaccine and related risk factors in dengue in a high incidence setting.

Authors:  Ruth Aralí Martínez-Vega; Alfonso J Rodriguez-Morales; Yalil Tomás Bracho-Churio; Mirley Enith Castro-Salas; Fredy Galvis-Ovallos; Ronald Giovanny Díaz-Quijano; María Lucrecia Luna-González; Jaime E Castellanos; José Ramos-Castañeda; Fredi Alexander Diaz-Quijano
Journal:  BMC Infect Dis       Date:  2016-11-25       Impact factor: 3.090

4.  A sharp decrease in reported non-COVID-19 notifiable infectious diseases during the first wave of the COVID-19 epidemic in the Rotterdam region, the Netherlands: a descriptive study.

Authors:  Ewout Fanoy; Helene Voeten; Babette van Deursen; Margot Hagenaars; Abraham Meima; Liselotte van Asten; Jan Hendrik Richardus
Journal:  BMC Infect Dis       Date:  2022-03-03       Impact factor: 3.090

5.  Infectious disease surveillance system descriptors: proposal for a comprehensive set.

Authors:  Julien Beauté; Bruno Christian Ciancio; Takis Panagiotopoulos
Journal:  Euro Surveill       Date:  2020-07

6.  Acute hepatitis C infection among adults with HIV in the Netherlands between 2003 and 2016: a capture-recapture analysis for the 2013 to 2016 period.

Authors:  T Sonia Boender; Eline Op de Coul; Joop Arends; Maria Prins; Marc van der Valk; Jan T M van der Meer; Birgit van Benthem; Peter Reiss; Colette Smit
Journal:  Euro Surveill       Date:  2020-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.